Ivan Rosenberg

7.2k total citations · 2 hit papers
247 papers, 5.9k citations indexed

About

Ivan Rosenberg is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Ivan Rosenberg has authored 247 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Molecular Biology, 65 papers in Organic Chemistry and 48 papers in Infectious Diseases. Recurrent topics in Ivan Rosenberg's work include DNA and Nucleic Acid Chemistry (106 papers), Advanced biosensing and bioanalysis techniques (54 papers) and Biochemical and Molecular Research (49 papers). Ivan Rosenberg is often cited by papers focused on DNA and Nucleic Acid Chemistry (106 papers), Advanced biosensing and bioanalysis techniques (54 papers) and Biochemical and Molecular Research (49 papers). Ivan Rosenberg collaborates with scholars based in Czechia, United States and United Kingdom. Ivan Rosenberg's co-authors include Antonı́n Holý, Erik De Clercq, Jan Balzarini, Takashi Sakuma, Masanori Baba, Rudi Pauwels, P. C. Maudgal, Miloš Buděšı́nský, Ivan Votruba and Radek Liboska and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Ivan Rosenberg

239 papers receiving 5.7k citations

Hit Papers

A novel selective broad-s... 1986 2026 1999 2012 1986 2008 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ivan Rosenberg 2.3k 2.0k 1.9k 1.1k 971 247 5.9k
Jan Konvalinka 2.3k 1.0× 1.5k 0.8× 499 0.3× 657 0.6× 1.5k 1.5× 171 5.7k
Deborah Fass 3.8k 1.7× 1.0k 0.5× 908 0.5× 318 0.3× 1.6k 1.7× 84 6.8k
Pietro Roversi 3.2k 1.4× 1.3k 0.7× 1.1k 0.6× 320 0.3× 188 0.2× 125 7.3k
Mark R. Wormald 8.6k 3.8× 531 0.3× 628 0.3× 3.3k 2.9× 1.1k 1.2× 173 12.8k
Werner Schäfer 1.2k 0.5× 755 0.4× 2.2k 1.1× 499 0.4× 678 0.7× 209 7.3k
Peter Henklein 4.0k 1.8× 896 0.5× 1.5k 0.8× 607 0.5× 1.4k 1.4× 165 6.8k
Tomáš Jelı́nek 2.4k 1.0× 1.6k 0.8× 569 0.3× 655 0.6× 59 0.1× 378 8.9k
Michal Hammel 6.4k 2.8× 580 0.3× 608 0.3× 158 0.1× 69 0.1× 117 8.5k
Nils Gunnar Johansson 948 0.4× 803 0.4× 397 0.2× 839 0.7× 281 0.3× 72 2.6k
E.A. Stura 5.2k 2.3× 833 0.4× 487 0.3× 618 0.6× 607 0.6× 172 10.4k

Countries citing papers authored by Ivan Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Ivan Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Rosenberg more than expected).

Fields of papers citing papers by Ivan Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Rosenberg. The network helps show where Ivan Rosenberg may publish in the future.

Co-authorship network of co-authors of Ivan Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Rosenberg. A scholar is included among the top collaborators of Ivan Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Rosenberg. Ivan Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mansell, Joanne, Frank R. Hendrickson, Lionel Cohen, et al.. (2022). Radiation Therapy Utilizing Fast Neutrons for Head and Neck Cancer - The Fermilab Experience. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information).
2.
Sebechlebská, Táňa, Viliam Kolivoška, Jakub Šebera, et al.. (2022). Additive transport in DNA molecular circuits. Journal of Materials Chemistry C. 10(33). 12022–12031. 4 indexed citations
3.
Pachl, Petr, et al.. (2018). Structure‐Based Optimization of Bisphosphonate Nucleoside Inhibitors of Human 5′(3′)‐deoxyribonucleotidases. European Journal of Organic Chemistry. 2018(37). 5144–5153.
4.
5.
Rosenberg, Ivan, et al.. (2014). Assessment of the dosimetric accuracies of CATPhan 504 and CIRS 062 using kV-CBCT for performing direct calculations. Journal of Medical Physics. 39(3). 133–133. 8 indexed citations
6.
Pachl, Petr, et al.. (2014). Structures of human cytosolic and mitochondrial nucleotidases: implications for structure-based design of selective inhibitors. Acta Crystallographica Section D Biological Crystallography. 70(2). 461–470. 4 indexed citations
7.
8.
Jones, Bleddyn & Ivan Rosenberg. (2005). Particle Therapy Co-operative Oncology Group (PTCOG 40) Meeting, Institute Curie 2004. British Journal of Radiology. 78(926). 99–102. 16 indexed citations
9.
Snåšel, Václav, Zdeněk Krejčík, Věra Jenčová, et al.. (2004). Integrase of Mason–Pfizer monkey virus. FEBS Journal. 272(1). 203–216. 12 indexed citations
10.
Kočišová, Eva, P. Praus, Ivan Rosenberg, et al.. (2004). Intracellular uptake of modified oligonucleotide studied by two fluorescence techniques. Biopolymers. 74(1-2). 110–114. 8 indexed citations
11.
Birkuš, Gabriel, Dominik Rejman, Miroslav Otmar, et al.. (2004). The Substrate Activity of (S)-9-[3-Hydroxy-(2-phosphonomethoxy)Propyl]Adenine Diphosphate toward DNA Polymerases α, δ and ε. Antiviral chemistry & chemotherapy. 15(1). 23–33. 6 indexed citations
12.
Masojı́dková, Milena, et al.. (2003). Study on Reactivity and Protection of the α-Hydroxyphosphonate Moiety in 5′-Nucleotide Analogues: Formation of the 3′-O-P-C(OH)-C4′ Internucleotide Linkage. Nucleosides Nucleotides & Nucleic Acids. 22(3). 329–347. 6 indexed citations
13.
Páv, Ondřej, Miloš Buděšı́nský, & Ivan Rosenberg. (2003). Ribo-,Xylo-, andArabino-Configured Adenine-Based Nucleoside Phosphonates: Synthesis of Monomers for Solid-Phase Oligonucleotide Assembly. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1053–1056. 1 indexed citations
14.
Snåšel, Václav, et al.. (2001). Inhibition of HIV‐1 integrase by modified oligonucleotides derived from U5′ LTR. European Journal of Biochemistry. 268(4). 980–986. 18 indexed citations
15.
Rejman, Dominik, Milena Masojı́dková, Erik De Clercq, & Ivan Rosenberg. (2001). 2′-C-ALKOXY AND 2′-C-ARYLOXY DERIVATIVES OFN-(2-PHOSPHONOMETHOXYETHYL)-PURINES AND -PYRIMIDINES: SYNTHESIS AND BIOLOGICAL ACTIVITY. Nucleosides Nucleotides & Nucleic Acids. 20(8). 1497–1522. 12 indexed citations
16.
Hanuš, Jaroslav, et al.. (1999). Raman spectroscopic study of triplex-like complexes of polyuridylic acid with the isopolar, non-isosteric phosphonate analogues of diadenosine monophosphate. Journal of Raman Spectroscopy. 30(8). 667–676. 18 indexed citations
17.
Alheit, H., Frank Saran, A.P. Warrington, et al.. (1999). Stereotactically guided conformal radiotherapy for meningiomas. Radiotherapy and Oncology. 50(2). 145–150. 44 indexed citations
18.
Vonka, Vladimı́r, et al.. (1990). Properties of a 9-(2-phosphonylmethoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant. Antiviral Research. 14(2). 117–121. 13 indexed citations
19.
Holý, Antonı́n, Ivan Votruba, Aleš Merta, et al.. (1990). Acyclic nucleotide analogues: Synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Research. 13(6). 295–311. 130 indexed citations
20.
Naesens, Lieve, Jan Balzarini, Ivan Rosenberg, Antonı́n Holý, & Erik De Clercq. (1989). 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo. European Journal of Clinical Microbiology & Infectious Diseases. 8(12). 1043–1047. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026